JP2014520090A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520090A5
JP2014520090A5 JP2014511911A JP2014511911A JP2014520090A5 JP 2014520090 A5 JP2014520090 A5 JP 2014520090A5 JP 2014511911 A JP2014511911 A JP 2014511911A JP 2014511911 A JP2014511911 A JP 2014511911A JP 2014520090 A5 JP2014520090 A5 JP 2014520090A5
Authority
JP
Japan
Prior art keywords
weight
component
preferred range
diacylglycerol
preferred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511911A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520090A (ja
JP6265888B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/059917 external-priority patent/WO2012160213A1/en
Publication of JP2014520090A publication Critical patent/JP2014520090A/ja
Publication of JP2014520090A5 publication Critical patent/JP2014520090A5/ja
Application granted granted Critical
Publication of JP6265888B2 publication Critical patent/JP6265888B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511911A 2011-05-25 2012-05-25 制御放出ペプチド製剤 Active JP6265888B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161489886P 2011-05-25 2011-05-25
US61/489,886 2011-05-25
PCT/EP2012/059917 WO2012160213A1 (en) 2011-05-25 2012-05-25 Controlled release peptide formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017228735A Division JP6415673B2 (ja) 2011-05-25 2017-11-29 制御放出ペプチド製剤

Publications (3)

Publication Number Publication Date
JP2014520090A JP2014520090A (ja) 2014-08-21
JP2014520090A5 true JP2014520090A5 (enExample) 2018-01-18
JP6265888B2 JP6265888B2 (ja) 2018-01-24

Family

ID=46456496

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014511911A Active JP6265888B2 (ja) 2011-05-25 2012-05-25 制御放出ペプチド製剤
JP2017228735A Active JP6415673B2 (ja) 2011-05-25 2017-11-29 制御放出ペプチド製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017228735A Active JP6415673B2 (ja) 2011-05-25 2017-11-29 制御放出ペプチド製剤

Country Status (37)

Country Link
US (3) US11433120B2 (enExample)
EP (2) EP2714004B1 (enExample)
JP (2) JP6265888B2 (enExample)
KR (1) KR102066755B1 (enExample)
CN (2) CN108283619B (enExample)
AR (1) AR086577A1 (enExample)
AU (2) AU2012260821B2 (enExample)
BR (1) BR112013030104A8 (enExample)
CA (1) CA2836847C (enExample)
CL (1) CL2013003365A1 (enExample)
CO (1) CO6900117A2 (enExample)
CR (1) CR20130653A (enExample)
CU (1) CU20130158A7 (enExample)
DK (1) DK2714004T3 (enExample)
DO (1) DOP2013000275A (enExample)
EA (1) EA036213B1 (enExample)
EC (1) ECSP13013107A (enExample)
ES (1) ES2984717T3 (enExample)
FI (1) FI2714004T3 (enExample)
GT (1) GT201300292A (enExample)
HR (1) HRP20240781T1 (enExample)
HU (1) HUE067389T2 (enExample)
IL (1) IL229376B (enExample)
LT (1) LT2714004T (enExample)
MX (1) MX361716B (enExample)
MY (1) MY177820A (enExample)
NI (1) NI201300127A (enExample)
PE (1) PE20141484A1 (enExample)
PH (1) PH12013502550A1 (enExample)
PL (1) PL2714004T3 (enExample)
PT (1) PT2714004T (enExample)
RS (1) RS65702B1 (enExample)
SG (1) SG194865A1 (enExample)
SI (1) SI2714004T1 (enExample)
TW (1) TWI624271B (enExample)
WO (1) WO2012160213A1 (enExample)
ZA (1) ZA201309653B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
EP2833918B1 (en) 2012-04-05 2019-05-08 Massachusetts Institute of Technology Immunostimulatory compositions and methods of use thereof
CN104487050B (zh) * 2012-05-25 2019-08-20 卡穆鲁斯公司 促生长素抑制素受体激动剂制剂
CN104661648B (zh) 2012-07-26 2019-04-05 卡姆拉斯公司 阿片样物质制剂
PE20150672A1 (es) 2012-07-26 2015-05-21 Camurus Ab Formulaciones de opioides
WO2018013924A1 (en) 2016-07-15 2018-01-18 Massachusetts Institute Of Technology Synthetic nanoparticles for delivery of immunomodulatory compounds
WO2018060213A1 (en) * 2016-09-27 2018-04-05 Camurus Ab Formulations containing a somatostatin receptor agonist
US11369617B2 (en) 2016-09-15 2022-06-28 Camurus Ab Prostacyclin analogue formulations
AU2017370692A1 (en) 2016-12-07 2019-06-06 Ra Pharmaceuticals, Inc. Modulators of complement activity
SG11202004373RA (en) * 2017-11-15 2020-06-29 Rhythm Pharmaceuticals Inc Sustained release peptide formulations
CN112203663A (zh) 2018-03-02 2021-01-08 伊莱西奥治疗有限公司 Cpg两亲分子及其用途
CN109091451B (zh) * 2018-09-10 2021-08-13 武汉百纳礼康生物制药有限公司 亲水性药物的油相液晶凝胶前体制剂及其制备方法
JP2022525781A (ja) 2019-03-20 2022-05-19 マサチューセッツ インスティテュート オブ テクノロジー 免疫細胞療法における両親媒性物質の使用およびそのための組成物
US12246055B2 (en) 2019-05-29 2025-03-11 Camurus Ab Lipid-controlled release compositions
CN113368041B (zh) * 2020-07-17 2023-01-03 丽珠医药集团股份有限公司 药物组合物、缓释制剂及其制备方法
IL308133A (en) * 2021-05-04 2023-12-01 Camurus Ab Compositions and methods for treating neuroendocrine tumors
WO2024263085A1 (en) * 2023-06-20 2024-12-26 Camurus Ab Compositions and methods for treating acromegaly
WO2025229403A1 (en) 2024-05-02 2025-11-06 Camurus Ab Lipid compositions and methods of use thereof
WO2025229402A1 (en) 2024-05-02 2025-11-06 Camurus Ab Lipid compositions and methods of use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046642A1 (en) * 2003-11-07 2005-05-26 Camurus Ab Compositions of lipids and cationic peptides
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
GB0417388D0 (en) 2004-08-04 2004-09-08 Camurus Ab Composition
CA2575906C (en) 2004-08-04 2014-04-15 Camurus Ab Compositions forming non-lamellar dispersions
SI1845942T1 (sl) * 2005-01-14 2014-06-30 Camurus Ab Gnrh analogne formulacije
JP5171262B2 (ja) * 2005-01-14 2013-03-27 カムルス エービー ソマトスタチン類似体製剤
CA2595385C (en) * 2005-01-21 2011-01-25 Camurus Ab Pharmaceutical lipid compositions
US20080200383A1 (en) * 2005-04-08 2008-08-21 Amylin Pharmaceuticals, Inc. Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
CN101217940B (zh) * 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1类似物制剂
GB0711656D0 (en) * 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) * 2007-08-22 2007-10-03 Camurus Ab Formulations
GB0815435D0 (en) * 2008-08-22 2008-10-01 Camurus Ab Formulations
US8931272B2 (en) * 2010-10-29 2015-01-13 Ford Global Technologies, Llc Method and system for limiting output of a boosted engine
EP2787974B1 (en) * 2011-12-05 2017-05-24 Camurus Ab Robust controlled-release peptide formulations
CN104487050B (zh) * 2012-05-25 2019-08-20 卡穆鲁斯公司 促生长素抑制素受体激动剂制剂
US20230285502A1 (en) * 2016-09-07 2023-09-14 Camurus Ab Mixtures and formulations
WO2018060213A1 (en) * 2016-09-27 2018-04-05 Camurus Ab Formulations containing a somatostatin receptor agonist

Similar Documents

Publication Publication Date Title
JP2014520090A5 (enExample)
JP2014102408A5 (enExample)
JP2013514381A5 (enExample)
JP2010219032A5 (enExample)
JP2013500200A5 (enExample)
JP2014517802A5 (enExample)
PL2630108T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
JP2012081521A5 (enExample)
JP2013510216A5 (enExample)
JP2015522045A5 (enExample)
JP2011177279A5 (enExample)
JP2012502876A5 (enExample)
JP2015520964A5 (enExample)
JP2015518492A5 (enExample)
JP2013508091A5 (enExample)
JP2012094862A5 (enExample)
EP2617752A4 (en) COMPOSITION AS LATENT HEAT POLYMERIZATION INITIATOR
JP2014500291A5 (enExample)
JP2012049345A5 (enExample)
JP2011242375A5 (enExample)
JP2013005790A5 (enExample)
JP2013531183A5 (enExample)
JP2014067585A5 (enExample)
JP2009055850A5 (enExample)
JP2016502452A5 (enExample)